A 10-year-old Boy with Microscopic Hematuria and Renal Biopsy Findings Mimicking Fabry Disease
5
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A, resulting in the accumulation of glycosphingolipids within the lysosomes of various cell types. It has a wide spectrum of clinical pheno types, and renal failure is a serious complication. Fabry disease is confirmed either by measurement of α-galactosidase A activity or by genetic testing for GLA muta tions. Renal biopsy findings on light microscopy, specifically enlarged podocytes with foamy cytoplasm, and osmiophilic inclusion bodies in the cytoplasm in all types of renal cells on electron microscopy, are characteristic of this disease. The predominant differential diagnosis is iatrogenic phospholipidosis in association with certain drugs that can cause cellular injuries indistinguishable from Fabry disease. Here, we report the case of a 10-year-old boy with microscopic hematuria who underwent a renal biopsy that showed morphological findings consistent with Fabry disease, although the patient had neither a GLA mutation nor a history of drug consumption. Six years later, spontaneous regression of this renal patho logy was observed in a second renal biopsy examination.
Abstract
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A, resulting in the accumulation of glycosphingolipids within the lysosomes of various cell types. It has a wide spectrum of clinical pheno types, and renal failure is a serious complication. Fabry disease is confirmed either by measurement of α-galactosidase A activity or by genetic testing for GLA muta tions. Renal biopsy findings on light microscopy, specifically enlarged podocytes with foamy cytoplasm, and osmiophilic inclusion bodies in the cytoplasm in all types of renal cells on electron microscopy, are characteristic of this disease. The predominant differential diagnosis is iatrogenic phospholipidosis in association with certain drugs that can cause cellular injuries indistinguishable from Fabry disease. Here, we report the case of a 10-year-old boy with microscopic hematuria who underwent a renal biopsy that showed morphological findings consistent with Fabry disease, although the patient had neither a GLA mutation nor a history of drug consumption. Six years later, spontaneous regression of this renal patho logy was observed in a second renal biopsy examination.
참고문헌 (17)
- Germain DP, "Fabry disease", Orphanet J Rare Dis, 5, pp.30~ (2010)
- Muller-Hocker J, "Chloroquine-induced phospholipidosis of the kidney mimicking Fabry’s disease : case report and review of the literature", Hum Pathol, 34, pp.285~289 (2003)
- von Scheidt W, "An atypical variant of Fabry’s disease with manifestations confined to the myocardium", N Engl J Med, 324, pp.395~399 (1991)
- Ko YH, "Atypical Fabry’s disease. An oligosymptomatic variant", Arch Pathol Lab Med, 120, pp.86~89 (1996)
- Germain DP, "Fabry Disease: Perspectives from 5 years of FOS" (2006), Oxford PharmaGenesis
- Germain DP, "Genetics of Fabry disease: diagnostic and therapeutic implications", Presse Med, 36(Spec No 1), pp.1S14~1S19 (2007)
- Banks DE, "Silicon nephropathy mimicking Fabry’s disease", Am J Nephrol, 3, pp.279~284 (1983)
- Albay D, "Chloroquine-induced lipidosis mimicking Fabry disease", Mod Pathol, 18, pp.733~738 (2005)
- Bracamonte ER, "Iatrogenic phospholipidosis mimicking Fabry disease", Am J Kidney Dis, 48, pp.844~850 (2006)
- Sessa A, "Renal pathological changes in Fabry disease", J Inherit Metab Dis, 24(Suppl 2), pp.66~70 (2001)
- Faraggiana T, "Light-and electron-microscopic histochemistry of Fabry’s disease", Am J Pathol, 103, pp.247~262 (1981)
- Alroy J, "Renal pathology in Fabry disease", J Am Soc Nephrol, 13(Suppl 2), pp.S134~S138 (2002)
- Scheurle C, "Renal phospholipidosis possibly induced by ranolazine", Clin Kidney J, 7, pp.62~64 (2014)
- Reasor MJ, "Drug-induced phospholipidosis : issues and future directions", Expert Opin Drug Saf, 5, pp.567~583 (2006)
- Hruban Z, "Drug-induced and naturally occurring myeloid bodies", Lab Invest, 27, pp.62~70 (1972)
- de Duve C, "Commentary. Lysosomotropic agents", BiochemPharmacol, 23, pp.2495~2531 (1974)
- Homewood CA, "Lysosomes, pH and the anti-malarial action of chloroquine", Nature, 235, pp.50~52 (1972)